We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A greyscale headshot of Kate Robinson

Kate Robinson profile page

Science Editor

 at Technology Networks


Kate graduated from Sheffield Hallam University with a bachelor's degree in biomedical sciences in 2020. During her studies, she developed a passion for science communication and after graduating, began a science blog in order to continue writing about trending science news and topics of interest. She joined the editorial team at Technology Networks in 2021. In her role as science editor Kate supports the publication’s in-house writers, produces scientific content across all communities and works closely with the managing editor to help coordinate commissioned pieces.


Education


Sheffield Hallam University  


Accreditations


Biomedical Science BSc (Hons) recognised by Sheffield Hallam University


Areas of Expertise



Got a Question for Kate Robinson?


Get in touch using the contact form linked here and we'll get back to you shortly.



Published Content
Total: 100
Molecular structure emerging from capsules, symbolizing drug discovery in functional proteomics.
Industry Insight

Advancing Drug Discovery With Functional Proteomics

Technology Networks spoke with Stefan Foser, vice president of global pharma at Bruker, to explore how they integrate instrumentation, software and consumables to support early-stage pharma innovation.
Hand holding a weight loss drug injector above a bathroom scale with feet in socks.
Article

The Promise and Perils of Weight Loss Drugs

This article examines the rise of GLP-1 weight loss drugs, highlighting their effectiveness in obesity and diabetes management while addressing concerns over side effects, mental health risks, high costs and long-term sustainability.
The gloved hands of a scientist holding badges displaying various LGBTQIA+ pride flags.
Listicle

Creating Space in Science: LGBTQIA+ Voices on Belonging in Pharma

In this listicle, LGBTQIA+ scientists offer insights into how inclusion can be built into everyday lab culture, from normalizing pronoun sharing and celebrating diverse holidays to rethinking policy and representation.
Infographic on Parkinson’s disease showing brain imaging and therapeutic approaches for symptom management.
Infographic

Parkinson’s Disease Mechanisms and Therapeutic Advances

This infographic outlines the mechanisms at the heart of PD and highlights investigational therapies, from gene and cell-based approaches to innovations targeting α-synuclein and neuroinflammation.

Transparent anatomical view of a human body highlighting internal organs, illustrating exposomics research.
Industry Insight

Exposomics Reveals the Environment’s Impact on Our Health

In this interview, Susan Bird, senior manager at Thermo Fisher Scientific, discusses the analytical challenges of identifying low-level exposures and how cutting-edge mass spectrometry platforms are advancing exposomics research.
Professor Christine Metz, within an illustrated notebook, next to the words "Women in Life Sciences Prof. Christine Metz"
Article

Research, Resilience and Reproductive Health: An Interview With Prof. Christine Metz

In this interview, Prof. Christine Metz discusses her journey into science, her groundbreaking research on endometriosis and the importance of funding and mentorship in advancing women's health and supporting women in STEMM.
Digital wireframe of a human figure symbolizing data-driven human-relevant models in science.
Industry Insight

Enhancing Drug Screening With Human-Relevant Models

In this interview, Sebastiaan J. Trietsch, Chief Technology Officer at MIMETAS, discusses how microphysiological systems are advancing drug discovery through scalable human-relevant models and AI integration.
Cells with transparent membranes and visible nuclei floating on a pink background.
Industry Insight

Revolutionizing Sample Storage With Hypothermic Preservation

The limitations of traditional cryopreservation are becoming increasingly apparent. In this interview, Alastair Carrington, CEO of Atelerix, explores how hypothermic preservation technology is transforming biopreservation.
Human silhouette composed of glowing molecules, symbolizing molecular networks in large-scale proteomics.
Industry Insight

Advancing Cancer Care Through Large-Scale Proteomics

In this interview, Asim Siddiqui, senior vice president and scientific fellow at Seer, explores the evolving role of unbiased proteomics in cancer research.
A molecular structure emerging from an open red and blue capsule, symbolizing drug discovery and pharmaceutical research.
Industry Insight

Tackling Previously “Undruggable” Proteins

In this interview, Dr. Christian Schafmeister discusses the structural advantages of Spiroligomer molecules, their ability to disrupt protein–protein interactions and their potential applications in cancer therapy and beyond.
Advertisement